We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $32B
1-Year Est. Return 32.86%
This Fund
S&P 500
This Quarter Est. Return
+12.76%
1 Year Est. Return
+32.86%
3 Year Est. Return
+108.44%
5 Year Est. Return
+138.89%
10 Year Est. Return
+505.54%
AUM
$22.2B
AUM Growth
+$2.18B
Cap. Flow
+$152M
Cap. Flow %
0.68%
Top 10 Hldgs %
45.51%
Holding
3,133
New
154
Increased
1,313
Reduced
1,267
Closed
93

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$65.6M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$61.6M
3
QCOM icon
Qualcomm
QCOM
+$59.1M
4
CME icon
CME Group
CME
+$58M
5
BKNG icon
Booking.com
BKNG
+$54.4M

Sector Composition

Rank Sector Weight
1 Technology 24.54%
2 Financials 10.86%
3 Communication Services 7.23%
4 Consumer Discretionary 7.21%
5 Industrials 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAFT icon
2701
Safety Insurance
SAFT
$1.52B
$1.19K ﹤0.01%
15
-200
-93% -$15.8K
VPG icon
2702
Vishay Precision Group
VPG
$864M
$1.18K ﹤0.01%
42
-60
-59% -$1.48K
PBYI icon
2703
Puma Biotechnology
PBYI
$442M
$1.17K ﹤0.01%
342
-75
-18% -$239
COLM icon
2704
Columbia Sportswear
COLM
$2.92B
$1.16K ﹤0.01%
19
-170
-90% -$10.9K
NL icon
2705
NLI Holdings
NL
$308M
$1.16K ﹤0.01%
181
-57
-24% -$429
BILL icon
2706
BILL Holdings
BILL
$4.91B
$1.16K ﹤0.01%
25
-503
-95% -$22.2K
GUTS icon
2707
Fractyl Health
GUTS
$107M
$1.16K ﹤0.01%
+714
New +$1.15K
ADCT icon
2708
ADC Therapeutics
ADCT
$144M
$1.15K ﹤0.01%
429
-5,317
-93% -$11.2K
BOC icon
2709
Boston Omaha
BOC
$429M
$1.14K ﹤0.01%
81
AQST icon
2710
Aquestive Therapeutics
AQST
$538M
$1.14K ﹤0.01%
343
+242
+240% +$694
GIPR icon
2711
Generation Income Properties
GIPR
$752K
$1.14K ﹤0.01%
77
LZM icon
2712
Lifezone Metals
LZM
$364M
$1.13K ﹤0.01%
+275
New +$1.02K
EIG icon
2713
Employers Holdings
EIG
$881M
$1.13K ﹤0.01%
24
-347
-94% -$16.7K
SCPH
2714
DELISTED
scPharmaceuticals
SCPH
$1.12K ﹤0.01%
295
+202
+217% +$627
SRCE icon
2715
1st Source
SRCE
$2.1B
$1.12K ﹤0.01%
18
ZBIO
2716
Zenas BioPharma
ZBIO
$2.02B
$1.11K ﹤0.01%
115
+87
+311% +$847
FATE icon
2717
Fate Therapeutics
FATE
$322M
$1.1K ﹤0.01%
987
-1,323
-57% -$1.54K
CRGX
2718
DELISTED
CARGO Therapeutics
CRGX
$1.1K ﹤0.01%
268
+188
+235% +$805
ULH icon
2719
Universal Logistics Holdings
ULH
$498M
$1.1K ﹤0.01%
43
-23
-35% -$570
TAYD icon
2720
Taylor Devices
TAYD
$166M
$1.08K ﹤0.01%
25
NMRA icon
2721
Neumora Therapeutics
NMRA
$300M
$1.07K ﹤0.01%
1,466
-8,224
-85% -$6.23K
CBAN icon
2722
Colony Bankcorp
CBAN
$465M
$1.07K ﹤0.01%
65
NWPX icon
2723
NWPX Infrastructure Inc
NWPX
$1.1B
$1.07K ﹤0.01%
26
TCRX icon
2724
TScan Therapeutics
TCRX
$50.1M
$1.06K ﹤0.01%
734
+382
+109% +$552
PLRX icon
2725
Pliant Therapeutics
PLRX
$64.4M
$1.06K ﹤0.01%
916
-252
-22% -$356

Similar funds

Nisa Investment Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Nisa Investment Advisors held 3,133 positions worth $22.2B, up 11% from $20B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Nisa Investment Advisors's Q2 2025 filing shows 154 new, 1,313 increased, 1,267 reduced and 93 closed positions. Its largest new stake was iShares Core US Aggregate Bond ETF: 3,987,632 shares worth $396M. The largest sale was NVIDIA, an estimated $65.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Communication Services.

  • Nisa Investment Advisors's largest Q2 2025 buy was iShares Core US Aggregate Bond ETF: 3,987,632 shares worth $396M.
  • Nisa Investment Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $611M increase.
  • Nisa Investment Advisors's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $65.6M.
  • Nisa Investment Advisors fully exited Vanguard FTSE All-World ex-US Small-Cap Index Fund in Q2 2025, selling an estimated $24.3M.
  • Nisa Investment Advisors's ten largest holdings make up 46% of its $22.2B portfolio in Q2 2025.
  • Nisa Investment Advisors opened 154 new positions and closed 93 in Q2 2025.
  • Nisa Investment Advisors's portfolio value rose 11% quarter-over-quarter to $22.2B.

Based on Nisa Investment Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.